Literature DB >> 20801459

The triglyceride to high-density lipoprotein-cholesterol ratio in adolescence and subsequent weight gain predict nuclear magnetic resonance-measured lipoprotein subclasses in adulthood.

Ram Weiss1, James D Otvos, Ronit Sinnreich, Andre R Miserez, Jeremy D Kark.   

Abstract

OBJECTIVE: To assess whether the fasting triglyceride-to-high-density lipoprotein (HDL)-cholesterol (TG/HDL) ratio in adolescence is predictive of a proatherogenic lipid profile in adulthood. STUDY
DESIGN: A longitudinal follow-up of 770 Israeli adolescents 16 to 17 years of age who participated in the Jerusalem Lipid Research Clinic study and were reevaluated 13 years later. Lipoprotein particle size was assessed at the follow-up with proton nuclear magnetic resonance.
RESULTS: The TG/HDL ratio measured in adolescence was strongly associated with low-density lipoprotein, very low-density lipoprotein (VLDL), and HDL mean particle size in young adulthood in both sexes, even after adjustment for baseline body mass index and body mass index change. The TG/HDL ratio measured in adolescence and subsequent weight gain independently predicted atherogenic small low-density lipoprotein and large VLDL particle concentrations (P < .001 in both sexes). Baseline TG/HDL and weight gain interacted to increase large VLDL concentration in men (P < .001).
CONCLUSIONS: Adolescents with an elevated TG/HDL ratio are prone to express a proatherogenic lipid profile in adulthood. This profile is additionally worsened by weight gain.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20801459     DOI: 10.1016/j.jpeds.2010.07.002

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

Review 1.  Cardiovascular risk in children and adolescents with type 2 diabetes mellitus.

Authors:  Christopher Prendergast; Samuel S Gidding
Journal:  Curr Diab Rep       Date:  2014-02       Impact factor: 4.810

2.  Surrogate lipid markers for small dense low-density lipoprotein particles in overweight youth.

Authors:  Stephen F Burns; So Jung Lee; Silva A Arslanian
Journal:  J Pediatr       Date:  2012-07-17       Impact factor: 4.406

3.  Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity.

Authors:  P Di Bonito; L Pacifico; C Chiesa; G Valerio; E Miraglia Del Giudice; C Maffeis; A Morandi; C Invitti; M R Licenziati; S Loche; G Tornese; F Franco; M Manco; M G Baroni
Journal:  J Endocrinol Invest       Date:  2016-11-16       Impact factor: 4.256

4.  Low-density lipoprotein cholesterol versus particle number in middle school children.

Authors:  Michele Mietus-Snyder; Kimberly L Drews; James D Otvos; Steven M Willi; Gary D Foster; Russell Jago; John B Buse
Journal:  J Pediatr       Date:  2013-02-14       Impact factor: 4.406

5.  Intramyocellular lipid is associated with visceral adiposity, markers of insulin resistance, and cardiovascular risk in prepubertal children: the EPOCH study.

Authors:  David E Brumbaugh; Tessa L Crume; Kristen Nadeau; Ann Scherzinger; Dana Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2012-04-16       Impact factor: 5.958

6.  Usefulness of the high triglyceride-to-HDL cholesterol ratio to identify cardiometabolic risk factors and preclinical signs of organ damage in outpatient children.

Authors:  Procolo Di Bonito; Nicola Moio; Carolina Scilla; Luigi Cavuto; Gerolamo Sibilio; Eduardo Sanguigno; Claudia Forziato; Francesco Saitta; Maria Rosaria Iardino; Carla Di Carluccio; Brunella Capaldo
Journal:  Diabetes Care       Date:  2011-10-31       Impact factor: 19.112

7.  Differences in the triglyceride to HDL-cholesterol ratio between Palestinian and Israeli adults.

Authors:  Ram Weiss; Hisham Nassar; Ronit Sinnreich; Jeremy D Kark
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

Review 8.  Insulin Resistance, Prediabetes, Metabolic Syndrome: What Should Every Pediatrician Know?

Authors:  Ahmad Ighbariya; Ram Weiss
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-12-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.